The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...
MBX Biosciences Inc. (NASDAQ:MBX) revealed results from its Phase 1 single ascending dose and multiple ascending dose trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback